0001104659-20-002747.txt : 20200109
0001104659-20-002747.hdr.sgml : 20200109
20200109180126
ACCESSION NUMBER: 0001104659-20-002747
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200101
FILED AS OF DATE: 20200109
DATE AS OF CHANGE: 20200109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herman Philip Karl
CENTRAL INDEX KEY: 0001799303
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 20519077
MAIL ADDRESS:
STREET 1: C/O Y-MABS THERAPEUTICS, INC.
STREET 2: 230 PARK AVENUE, SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
3
1
a3.xml
3
X0206
3
2020-01-01
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001799303
Herman Philip Karl
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE, SUITE 3350
NEW YORK
NY
10169
0
1
0
0
Sr. VP and CCO
Employee Stock Option (right to buy)
13.11
2028-10-07
Common Stock
20000
D
Employee Stock Option (right to buy)
21.45
2029-06-12
Common Stock
20000
D
Employee Stock Option (right to buy)
33.74
2029-12-10
Common Stock
20000
D
The stock option vested and became exercisable as to 25% of the shares subject to the option on 10/07/2019 and thereafter vests and becomes exercisable by 1/48th in equal monthly instalments, subject to continued employment of the Reporting Person at such times.
The stock option vests and becomes exercisable as to 25% of the shares subject to the option on 6/12/2020 and thereafter vests and becomes exercisable by 1/48th in equal monthly instalments, subject to continued employment of the Reporting Person at such times.
The stock option vests and becomes exercisable as to 25% of the shares subject to the option on 12/10/2020 and thereafter vests and becomes exercisable by 1/48th in equal monthly instalments, subject to continued employment of the Reporting Person at such times.
s/s Philip Karl Herman
2020-01-09